₹10.25
NSE close, 16 Nov 2026
−58.92%
MONO PHARMACARE is a small cap company, listed on NSE SME under the symbol MONOPHARMA. At ₹10.25 a share, the market values the whole company at ₹18 crore. NSE SME is the exchange's platform for small and medium companies, which report their results every half year.
In FY26, it reported sales of ₹166 crore and a net profit of ₹0 crore, an operating margin of 2.4%.
The market values the company at 51.7 times its profit over the last twelve months and 0.57 times its book value; its return on equity is 1.1% and its borrowings are 1.79 times its equity.
Promoters hold 56.76% of the shares. Foreign institutions hold 0.00%, and domestic institutions, mutual funds among them, 0.00%.
Over the past year the share price has fallen 50.0%, and it is 53.5% below its 52-week high.
Listed on NSE SME, the platform for small and medium companies: its shares trade in large lots and often thinly, so the price can move sharply on a few trades, and companies file results every half year.
₹ crore. Consolidated figures.
| Line | Sep 2023 | Mar 2024 | Sep 2024 | 6M to Mar 2025 | 6M to Sep 2025 | 6M to Mar 2026 |
|---|---|---|---|---|---|---|
| Sales | 66.5 | 55.8 | 87.2 | 81.2 | 66.3 | 99.4 |
| Expenses |
Has informed regarding Submission of the Compliance Report on Corporate Governance for the Q2 FY 2026-27
Integrated filing governance for quarter 2 2026-27
Integrated filing governance for quarter 1 2026-27
Has informed regarding Submission of the Compliance Report on Corporate Governance for the Q1 FY 2026-27
| 62.7 |
| 53.4 |
| 82.4 |
| 78.3 |
| 64.5 |
| 97.2 |
| Operating profit | 3.9 | 2.5 | 4.7 | 2.9 | 1.8 | 2.2 |
|---|
| Operating margin | 5.8% | 4.4% | 5.4% | 3.6% | 2.7% | 2.2% |
|---|
| Other income | 0.0 | 0.1 | 0.0 | 0.9 | 0.0 | 0 |
|---|
| Interest | 1.5 | 1.6 | 1.6 | 2.5 | 1.6 | 1.7 |
|---|
| Depreciation | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
|---|
| Profit before tax | 2.4 | 0.9 | 3.2 | 1.3 | 0.1 | 0.5 |
|---|
| Tax | 0.5 | 0.3 | 0.9 | 0.6 | 0.1 | 0.1 |
|---|
| Net profit | 1.9 | 0.6 | 2.3 | 0.7 | 0.0 | 0.3 |
|---|
| EPS (₹) | 1.43 | 0.38 | 1.30 | 0.45 | 0.00 | 0.19 |
|---|
₹ crore, financial years to March.
₹ crore, at each year's end and the latest half year.
₹ crore, by financial year, and the latest half year.
Margins, returns, debt, tax and cash.
| Line | FY24 | FY25 | FY26 |
|---|---|---|---|
| Net margin | 2.0% | 1.8% | 0.2% |
| Operating margin | 5.2% | 4.5% | 2.4% |
| Return on equity | 8.7% | 9.9% | 1.1% |
| Return on capital employed | 9.1% | 10.0% | 4.4% |
| Return on assets | 3.0% | 2.8% | 0.3% |
| Debt to equity | 1.47 | 1.72 | 1.79 |
| Interest coverage | 2.00 | 2.10 | 1.20 |
| Debt to assets | 0.51 | 0.49 | 0.46 |
| Current ratio | 2.24 | 2.06 | 1.92 |
| Quick ratio | 1.06 | 1.02 | 1.25 |
| Cash ratio | 0.01 | 0.01 | 0.02 |
| Asset turnover | 1.51 | 1.53 | 1.35 |
| Fixed asset turnover | 134.44 | 171.78 | 188.28 |
| Inventory turnover | – | 2.70 | 3.70 |
| Receivables turnover | 3.90 | 4.00 | 2.20 |
| Gross margin | – | 9.5% | 5.3% |
| Cash from operations to profit | -360.0% | -139.0% | 657.0% |
| Effective tax rate | 23.8% | 30.5% | 37.9% |
A copy Srutinizers report of Annual General Meeting held on September 30, 2026. Further, the company has informed the Exchange regarding voting results.
Proceedings of Annual General Meeting held on September 30, 2026
Record date for the purpose of Meeting is 23-Sep-2026.
Board comment on fine levied
Notice of Annual General Meeting to be held on September 30, 2026
Outcome of Board Meeting held on September 03, 2026.
General Updates regarding the re-appointment of Secretarial Auditor of the company.
Change in Auditors of the company.
The financial results for the period ended March 31, 2026.
Resignation of Mr Rahul Joshi as Company Secretary & Compliance Officer of the company w.e.f. July 01, 2026.